Health claims
This article was originally published in The Tan Sheet
Executive Summary
FDA is expecting "imminent publication" of the folic acid proposals as well as a document "reopening" the comment period for "health claim topics which were not approved in the January publication" of the Nutrition Labeling & Education Act regulations, FDA's Office of Special Nutritionals Director Elizabeth Yetley, PhD, tells the Council for Responsible Nutrition annual conference on Sept. 23. The health claim topics include: zinc and immune function in the elderly; folic acid and neural tube defects; omega-3 fatty acids and coronary heart disease; antioxidants and cancer; and dietary fiber and cancer/cardiovascular disease. Yetley also said that a public conference to discuss antioxidant health claims is slated for Nov. 1-3 in Washington, D.C. ("The Tan Sheet" Sept. 20, In Brief), and that a similar conference on dietary fiber and cancer/heart disease will be held "sometime after the first of the calendar year".
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning